PREVENTION OF NEPHRITIS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-DEFICIENT MRL-LPR MICE

被引:191
作者
JEVNIKAR, AM
GRUSBY, MJ
GLIMCHER, LH
机构
[1] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
[2] UNIV WESTERN ONTARIO, DEPT MED, LONDON N6A 5A5, ONTARIO, CANADA
[3] UNIV WESTERN ONTARIO, DEPT MICROBIOL & IMMUNOL, LONDON N6A 5A5, ONTARIO, CANADA
[4] UNIV WESTERN ONTARIO, ROBARTS RES INST, LONDON N6A 5A5, ONTARIO, CANADA
[5] HARVARD UNIV, SCH PUBL HLTH, DEPT CANC BIOL, BOSTON, MA 02115 USA
关键词
D O I
10.1084/jem.179.4.1137
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MRL-1pr mice develop aggressive autoimmune kidney disease associated with increased or de novo renal expression of major histocompatibility complex (MHC) class II molecules and a massive systemic expansion of CD4-CD- double negative (DN) T cells. Whereas non-MHC linked genes can have a profound effect on the development of nephritis, lymphadenopathy, and anti-DNA antibody production in MRL-1pr mice, the role of MHC molecules has not been unequivocally established. To study the role of MHC class II in this murine model of systemic lupus erythematosis, class II-deficient MRL-1pr mice (MRL-1pr -/-) were created. MRL-1pr -/- mice developed lymphadenopathy but not autoimmune renal disease or autoantibodies. This study demonstrates that class II expression is critical for the development of autoaggressive CD4+ T cells involved in autoimmune nephritis and clearly dissociates DN T cell expansion from autoimmune disease initiation.
引用
收藏
页码:1137 / 1143
页数:7
相关论文
共 29 条
[1]   TREATMENT OF (NZBXNZW)F1 DISEASE WITH ANTI-I-A MONOCLONAL-ANTIBODIES [J].
ADELMAN, NE ;
WATLING, DL ;
MCDEVITT, HO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) :1350-1355
[2]   THE DEFECT IN FAS MESSENGER-RNA EXPRESSION IN MRL LPR MICE IS ASSOCIATED WITH INSERTION OF THE RETROTRANSPOSON, ETN [J].
CHU, JL ;
DRAPPA, J ;
PARNASSA, A ;
ELKON, KB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :723-730
[3]   AUTOREACTIVE KIDNEY-INFILTRATING T-CELL CLONES IN MURINE LUPUS NEPHRITIS [J].
GALLO, CD ;
JEVNIKAR, AM ;
BRENNAN, DC ;
FLORQUIN, S ;
PACHECOSILVA, A ;
KELLEY, VR .
KIDNEY INTERNATIONAL, 1992, 42 (04) :851-859
[4]  
GIESE T, 1992, J IMMUNOL, V149, P3097
[5]   EFFECT OF ANTI-CD4 ANTIBODY TREATMENT ON INFLAMMATORY ARTHRITIS IN MRL-LPR/LPR MICE [J].
GILKESON, GS ;
SPURNEY, R ;
COFFMAN, TM ;
KURLANDER, R ;
RUIZ, P ;
PISETSKY, DS .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (02) :166-172
[6]   DEPLETION OF CD4+ T-CELLS IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DEFICIENT MICE [J].
GRUSBY, MJ ;
JOHNSON, RS ;
PAPAIOANNOU, VE ;
GLIMCHER, LH .
SCIENCE, 1991, 253 (5026) :1417-1420
[7]  
HERRON LR, 1993, J IMMUNOL, V151, P3450
[8]  
IZUI S, 1984, J IMMUNOL, V133, P227
[9]   ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY SUPPRESSES AUTOIMMUNE-DISEASE IN MRL/MP-LPR/LPR MICE [J].
JABS, DA ;
BUREK, CL ;
HU, Q ;
KUPPERS, RC ;
LEE, B ;
PRENDERGAST, RA .
CELLULAR IMMUNOLOGY, 1992, 141 (02) :496-507
[10]   REACTIVE LYMPHOCYTES IN LACRIMAL GLAND AND VASCULITIC RENAL LESIONS OF AUTOIMMUNE MRL/LPR MICE EXPRESS L3T4 [J].
JABS, DA ;
PRENDERGAST, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :1198-1203